| Description | Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) directed against waveform proteins thathas anti-HBV effects and can be used to study rheumatoid arthritis, |
| Synonyms | hzVSF-v13 |
| molecular weight | N/A |
| CAS | 2460809-80-5 |
| Storage | store at low temperature | store at -20°C |
| References | 1. Prasenohadi Prasenohadi, et al. Double-Blind, Randomized, Placebo-Controlled Study on hzVSF-v13, a Novel Anti-Vimentin Monoclonal Antibody Drug as Add-on Standard of Care in the Management of Patients with Moderate to Severe COVID-19. J Clin Med. 2022 May 24;11(11):2961. |